The purpose of this study was to examine whether intracellular metallothion
ein (MT) protects against acetaminophen hepatotoxicity. MT-I/II knockout (M
T-null) and control mice were given acetaminophen (150-500 mg/kg i.p.), and
liver injury was assessed 24 h later. MT-null mice were more susceptible t
han controls to acetaminophen-induced lethality and hepatotoxicity, as evid
enced by elevated serum enzyme activities and histopathology. Zinc pretreat
ment, a method of MT induction, protected against acetaminophen hepatotoxic
ity in control mice, but not in MT-null mice. The susceptibility of MT-null
mice to acetaminophen hepatotoxicity was not due to the increased acetamin
ophen bioactivation, as cytochrome P-450 enzymes, and acetaminophen-reactiv
e metabolites in bile and urine were not increased in MT-null mice. Western
blots of liver cytosol indicated that acetaminophen covalent binding at 4h
increased with acetaminophen dose, but there was nd consistent difference
between control and MT-null mice. Acetaminophen injection depleted cellular
glutathione similarly in both control and MT-null mice, but produced more
lipid peroxidation in MT-null mice, as evidenced by the abundance of thioba
rbiturate-reactive substances, and by immunohistochemical localization of 4
-hydroxynonenal and malondialdehyde protein adducts. MT-null hepatocytes we
re more susceptible than control Cells to oxidative stress and cytotoxicity
produced by N-acetylbenzoquinoneimine, a reactive metabolite of acetaminop
hen, as determined by oxidation of 2',7'-dichlorofluorescin diacetate and l
actate dehydrogenase leakage. In summary, this study demonstrated that MT d
eficiency renders animals more vulnerable to acetaminophen-induced hepatoto
xicity. The Increased sensitivity does not appear to be due to increased ac
etaminophen activation, glutathione depletion, or covalent binding, but app
ears to be associated with the antioxidant role of MT.